Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous MalformationsTRANSLATIONAL STROKE RESEARCHIF4.32024-07-091PRE
Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 SignalingARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42024-06-012PRE
Histopathologic and Transcriptomic Characterizations of Cerebral Microbleeds in an E4FAD Murine ModelSTROKEIF8.92024-02-010PRE
Transcriptomic signatures of individual cell types in cerebral cavernous malformationCELL COMMUNICATION AND SIGNALINGIF8.92024-01-094OAAI
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingSTROKEIF8.92024-01-011PRE
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult MiceSTROKEIF8.92023-11-014OA
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angiomaCOMMUNICATIONS MEDICINEIF6.32023-03-038OA
In Vivo Permeability Of The Aging Brain With Cerebral Microbleeds脑微出血的衰老大脑的体内通透性STROKEIF8.92023-02-010PRE
Multiplexed Histopathological Characterization Of Cerebral Microbleeds In The Aging BrainSTROKEIF8.92023-02-010PRE
Plasma Proteins In Correlation With Lesional Iron Content And Permeability Imaging In Clinical Trial Of Cavernous Angioma With Symptomatic HemorrhageSTROKEIF8.92023-02-010PRE
Propranolol as therapy for cerebral cavernous malformations: a cautionary noteJOURNAL OF TRANSLATIONAL MEDICINEIF7.52022-04-056OAAI
Multi-omic Biomarker Development In A Mendelian Neurovascular Disease, Cavernous AngiomaSTROKEIF8.92022-02-010PRE
A Framework For The Study Of Hemorrhagic Microangiopathy With Cerebral Cavernous Malformation As A ParadigmSTROKEIF8.92022-02-010PRE
Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and GrowthJOURNAL OF MAGNETIC RESONANCE IMAGINGIF3.52021-09-249OA